H4R antagonist JNJ-7777120 reduces traumatic brain injury damage via ERK1/2/NF-κB pathway inhibition in rats
This preclinical study demonstrates that JNJ-7777120, a histamine H4 receptor antagonist, improves motor and sensory function in rats with mild traumatic brain injury by reducing neuroinflammation, apoptosis, and oxidative stress. The neuroprotective effects occur through blockade of ERK1/2/NF-κB signaling pathways.